The disease-resistant patients exposing Covid-19's weak spots Ying Tang/Getty Images There are some people whose bodies have reacted differently to Covid-19 compared to the rest of the population Some people are unusually resilient to the coronavirus, so scientists are now searching their genes and blood in the hope of finding the pandemic's Achilles' heel. "The idea is to try and …
A World Health Organization trial of Gilead Sciences Inc.’s remdesivir, the antiviral drug used to treat US President Donald Trump, showed little or no effect on the survival rates of covid patients, a result that is in variance with the trial reports of the drugmaker. The WHO trial, which also studied the effect of hydroxychloroquine, a combination of HIV drugs …
The WHO’s Solidarity Therapeutics Trial was conducted in 11,266 adult patients in 405 hospitals across more than 30 countries. The World Health Organization’s Solidarity trial is the world’s largest ongoing randomized control trial of potential COVID-19 therapeutics. Based on data collected from the trial, the WHO has released an interim report of patients’ responses to repurposed drugs for COVID-19 treatment. …
Interim results from the World Health Organization’s solidarity trial showed that Gilead Sciences Inc’s remdesivir showed little or no effect for covid-19 patients, a result which was significantly different from the positive results shown by Gilead’s own trial. “These remdesivir, hydroxychloroquine, lopinavir and interferon regimens appeared to have little or no effect on hospitalized covid-19 patients, as indicated by overall …